Valiant Organics Limited
NSE:VALIANTORG.NS
401.25 (INR) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 7,230.594 | 10,518.048 | 11,532.711 | 7,548.077 | 6,749.335 | 6,923.025 | 1,206.447 | 579.904 | 520.994 | 590.379 | 425.098 | 339.945 | 326.767 |
| Cost of Revenue
| 4,885.886 | 6,884.762 | 8,126.39 | 4,413.771 | 4,586.61 | 4,788.133 | 850.331 | 379.542 | 251.175 | 371.555 | 257.249 | 202.306 | 180.069 |
| Gross Profit
| 2,344.708 | 3,633.286 | 3,406.321 | 3,134.306 | 2,162.725 | 2,134.891 | 356.116 | 200.361 | 269.819 | 218.824 | 167.849 | 137.639 | 146.698 |
| Gross Profit Ratio
| 0.324 | 0.345 | 0.295 | 0.415 | 0.32 | 0.308 | 0.295 | 0.346 | 0.518 | 0.371 | 0.395 | 0.405 | 0.449 |
| Reseach & Development Expenses
| 10 | 7.467 | 5.022 | 2.523 | 2.365 | 1.747 | 1.099 | 0.808 | 0.187 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 355.575 | 74.446 | 57.207 | 53.737 | 44.595 | 47.684 | 9.322 | 17.126 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 137.898 | 173.256 | 182.916 | 134.929 | 71.888 | 70.531 | 29.848 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 493.473 | 247.702 | 240.123 | 188.666 | 116.483 | 118.214 | 39.17 | 17.126 | 88.851 | 21.422 | 17.891 | 11.648 | 0 |
| Other Expenses
| 93.007 | 80.326 | 35.746 | 28.645 | 30.936 | 14.941 | -3.518 | -2.394 | 119.242 | 114.117 | 93.987 | 85.529 | 88.875 |
| Operating Expenses
| 2,311.457 | 2,282.861 | 1,610.629 | 1,270.583 | 502.252 | 436.175 | 109.777 | 48.335 | 119.242 | 114.117 | 93.987 | 85.529 | 88.875 |
| Operating Income
| 126.258 | 1,355.782 | 1,761.547 | 1,872.061 | 1,682.741 | 1,698.716 | 246.339 | 154.117 | 157.521 | 109.359 | 81.985 | 60.513 | 59.417 |
| Operating Income Ratio
| 0.017 | 0.129 | 0.153 | 0.248 | 0.249 | 0.245 | 0.204 | 0.266 | 0.302 | 0.185 | 0.193 | 0.178 | 0.182 |
| Total Other Income Expenses Net
| -213.19 | 16.02 | 0.154 | -23.459 | 2.13 | 13.428 | 6.002 | -0.304 | 6.944 | 4.652 | 8.122 | 8.402 | 1.593 |
| Income Before Tax
| -86.932 | 1,371.802 | 1,761.702 | 1,848.601 | 1,828.015 | 1,712.144 | 252.341 | 151.723 | 157.521 | 109.359 | 81.984 | 60.512 | 59.416 |
| Income Before Tax Ratio
| -0.012 | 0.13 | 0.153 | 0.245 | 0.271 | 0.247 | 0.209 | 0.262 | 0.302 | 0.185 | 0.193 | 0.178 | 0.182 |
| Income Tax Expense
| -2.967 | 346.155 | 482.574 | 539.899 | 422.686 | 499.641 | 88.964 | 53.383 | 54.457 | 36.63 | 26.57 | 20.253 | 20.239 |
| Net Income
| -83.912 | 881.214 | 1,132.838 | 1,145.639 | 1,239.273 | 1,332.354 | 163.377 | 98.34 | 103.064 | 72.729 | 55.413 | 40.258 | 39.178 |
| Net Income Ratio
| -0.012 | 0.084 | 0.098 | 0.152 | 0.184 | 0.192 | 0.135 | 0.17 | 0.198 | 0.123 | 0.13 | 0.118 | 0.12 |
| EPS
| -3.04 | 32.45 | 41.72 | 44.68 | 25.5 | 48.32 | 13.93 | 9.9 | 14.07 | 9.99 | 7.61 | 5.53 | 5.38 |
| EPS Diluted
| -3.04 | 31.5 | 40.51 | 40.97 | 22.16 | 48.32 | 13.93 | 9.9 | 14.07 | 9.99 | 7.61 | 5.53 | 5.38 |
| EBITDA
| 459.86 | 1,722.644 | 2,127.027 | 2,112.942 | 1,851.163 | 1,865.022 | 270.413 | 162.904 | 159.843 | 111.672 | 81.309 | 59.494 | 66.608 |
| EBITDA Ratio
| 0.064 | 0.164 | 0.184 | 0.28 | 0.274 | 0.269 | 0.224 | 0.281 | 0.307 | 0.189 | 0.191 | 0.175 | 0.204 |